| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,720,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile HCW Biologics is a biopharmaceutical company focused on discovering and developing immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. Co. has selected two molecules as its primary product candidates: HCW9218 and HCW9302. HCW9218 is designed to treat the impact of accumulated senescent cells and the Senescence-Associated Secretory Phenotype (SASP) factors which they secrete by eliminating senescent cells and reducing SASP factors. HCW9302 is designed to activate and expand regulatory T cells to suppress the activity of inflammasome-bearing cells and the inflammatory factors which they secrete.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
129,008 |
505,416 |
| Total Buy Value |
$0 |
$0 |
$253,088 |
$1,101,173 |
| Total People Bought |
0 |
0 |
4 |
5 |
| Total Buy Transactions |
0 |
0 |
21 |
53 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Byam Rebecca |
Chief Financial Officer |
• – – |
2022-08-31 |
4 |
B |
$2.56 |
$25,572 |
D/D |
10,000 |
282,952 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-08-30 |
4 |
B |
$2.55 |
$18,341 |
D/D |
7,200 |
272,952 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-08-29 |
4 |
B |
$2.57 |
$25,662 |
D/D |
10,000 |
265,752 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-08-26 |
4 |
B |
$2.54 |
$25,358 |
D/D |
10,000 |
255,752 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-08-25 |
4 |
B |
$2.59 |
$104,522 |
D/D |
40,300 |
245,752 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-08-24 |
4 |
B |
$2.50 |
$125,225 |
D/D |
50,000 |
205,452 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-06-14 |
4 |
B |
$2.46 |
$144,986 |
D/D |
58,856 |
155,452 |
2.74 |
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2022-06-13 |
4 |
B |
$2.08 |
$15,813 |
D/D |
7,596 |
96,596 |
2.74 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2022-06-10 |
4 |
B |
$2.19 |
$3,326 |
D/D |
1,520 |
15,286,468 |
2.73 |
- |
|
| Winer Gary M |
Director |
– • – |
2022-06-10 |
4 |
B |
$2.13 |
$3,200 |
D/D |
1,500 |
13,000 |
2.31 |
- |
|
| Winer Gary M |
Director |
– • – |
2022-06-09 |
4 |
B |
$2.20 |
$2,200 |
D/D |
1,000 |
11,500 |
2.31 |
- |
|
| Winer Gary M |
Director |
– • – |
2022-06-08 |
4 |
B |
$2.27 |
$2,273 |
D/D |
1,000 |
10,500 |
2.31 |
- |
|
| Winer Gary M |
Director |
– • – |
2022-06-07 |
4 |
B |
$2.10 |
$2,100 |
D/D |
1,000 |
9,500 |
2.31 |
- |
|
| Winer Gary M |
Director |
– • – |
2022-06-06 |
4 |
B |
$2.13 |
$2,127 |
D/D |
1,000 |
8,500 |
2.31 |
- |
|
| Greene Rick S. |
Director |
– • – |
2022-06-02 |
4 |
B |
$2.09 |
$10,041 |
D/D |
4,800 |
8,411 |
2.39 |
- |
|
| Jiao Jin-An |
VP of Development |
• – – |
2022-05-31 |
4 |
OE |
$0.14 |
$2,160 |
D/D |
14,570 |
45,141 |
|
- |
|
| Rhode Peter |
See Remarks |
• – – |
2022-01-14 |
4 |
OE |
$0.14 |
$360 |
D/D |
1,715 |
48,500 |
|
- |
|
| Jiao Jin-An |
VP of Development |
• – – |
2021-12-06 |
4 |
B |
$2.42 |
$24,150 |
D/D |
10,000 |
30,571 |
2.74 |
- |
|
| Flowers Lee |
SVP of Business Development |
• – – |
2021-12-01 |
4 |
OE |
$0.14 |
$600 |
D/D |
4,285 |
95,952 |
|
- |
|
| Byam Rebecca |
Chief Financial Officer |
• – – |
2021-11-23 |
4 |
OE |
$0.14 |
$3,780 |
D/D |
27,000 |
89,000 |
|
- |
|
| Giles Lisa M. |
Director |
– • – |
2021-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100 |
|
- |
|
| Winer Gary M |
Director |
– • – |
2021-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,500 |
|
- |
|
| Medmira Capital Ltd. |
10% Owner |
– – • |
2021-09-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,587,659) |
0 |
|
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2021-08-31 |
4/A |
B |
$3.94 |
$22,970 |
D/D |
5,830 |
15,281,948 |
2.81 |
- |
|
| Wong Hing C |
Chief Executive Officer |
• • – |
2021-08-31 |
4 |
B |
$3.93 |
$15,070 |
D/D |
3,830 |
15,277,948 |
2.81 |
- |
|
91 Records found
|
|
Page 3 of 4 |
|
|
